Paul Riley/LinkedIn
Jul 18, 2026, 11:54
Paul Riley: Presenting STAR Max3 at ISTH 2026
Paul Riley, Scientific Marketing Manager at Diagnostica Stago, shared a post on LinkedIn:
“Showing our FDA submission data for the STAR Max3 at ISTH – always a privilege to attend and present at ISTH, with this meeting especially meaningful because it is taking place in Paris, the location for my first ISTH 25 years ago!
A quarter century of being witness to all of the change in the field and also International Society on Thrombosis and Haemostasis (ISTH)‘s growth as an organization clinical laboratory wtd2026.
I really do feel privileged to be involved with ISTH during these times.
I will miss Paris but will make it back soon enough.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Sep 1, 2026, 18:13Ramsha Batool: Chemotherapy-Induced Anemia Impacts Quality of Life in Breast Cancer
-
Sep 1, 2026, 18:09Natalya Shynhera: Using Anemia to Teach Medical English in Real Clinical Practice
-
Sep 1, 2026, 18:06Wei Du: New Therapeutic Potential for PARP Inhibitors in MLL-Rearranged Leukemia
-
Sep 1, 2026, 18:03Tobias Tichelbäcker: PRAGUE-26 Shows Catheter Lysis Beats Anticoagulation Without Ultrasound
-
Sep 1, 2026, 18:00Baptiste Thibault: My First Publication as First Author on Ionized Calcium Monitoring Before Citrate-CRRT
-
Sep 1, 2026, 17:51Nadezhda Vasilyeva: Shifting the Boundaries of Acute Ischemic Stroke Management
-
Sep 1, 2026, 17:49Malik Ghannam: Recent Venous Thrombosis Risk Factors May Help Explain Cryptogenic Stroke in Young Adults
-
Sep 1, 2026, 17:42Rishabh Jain: Renal Artery FMD Is Managed With Balloon Angioplasty Alone
-
Sep 1, 2026, 17:42Caitlin R: The Brain’s Need to Find Patterns